Sleep-Disordered Breathing in Progressive Supranuclear Palsy

Sleep-Disordered Breathing in Progressive Supranuclear Palsy

Overview

Sleep-disordered breathing (SDB) represents a significant yet under-recognized complication of progressive supranuclear palsy (PSP), with profound implications for disease progression, quality of life, and survival. Unlike the well-characterized motor and cognitive manifestations of PSP, respiratory dysfunction during sleep has received relatively limited attention in the clinical literature, despite its substantial impact on patient outcomes.

The pathophysiology of SDB in PSP is multifactorial, involving brainstem respiratory centers, upper airway musculature, and the neurogenic control of breathing. Understanding these mechanisms is essential for comprehensive management and may reveal novel therapeutic targets.

Epidemiology of Sleep-Disordered Breathing in PSP

Prevalence Data

Sleep-disordered breathing is highly prevalent in PSP populations:

• Obstructive Sleep Apnea (OSA): 40-60% of PSP patients meet diagnostic criteria[@gaig2024]
• Central Sleep Apnea (CSA): 15-25% of patients[@terzaghi2023]
• Cheyne-Stokes Breathing Pattern: 10-20%[@shen2024]
• Nocturnal Hypoventilation: 20-30%[@chiu2022]
• Any SDB: Over 70% of PSP patients demonstrate some form of sleep-disordered breathing

This prevalence substantially exceeds that seen in age-matched healthy controls and is comparable to or exceeds rates observed in other neurodegenerative disorders.

Risk Factors

Several factors increase SDB risk in PSP:

...

Sleep-Disordered Breathing in Progressive Supranuclear Palsy

Overview

Sleep-disordered breathing (SDB) represents a significant yet under-recognized complication of progressive supranuclear palsy (PSP), with profound implications for disease progression, quality of life, and survival. Unlike the well-characterized motor and cognitive manifestations of PSP, respiratory dysfunction during sleep has received relatively limited attention in the clinical literature, despite its substantial impact on patient outcomes.

The pathophysiology of SDB in PSP is multifactorial, involving brainstem respiratory centers, upper airway musculature, and the neurogenic control of breathing. Understanding these mechanisms is essential for comprehensive management and may reveal novel therapeutic targets.

Epidemiology of Sleep-Disordered Breathing in PSP

Prevalence Data

Sleep-disordered breathing is highly prevalent in PSP populations:

• Obstructive Sleep Apnea (OSA): 40-60% of PSP patients meet diagnostic criteria[@gaig2024]
• Central Sleep Apnea (CSA): 15-25% of patients[@terzaghi2023]
• Cheyne-Stokes Breathing Pattern: 10-20%[@shen2024]
• Nocturnal Hypoventilation: 20-30%[@chiu2022]
• Any SDB: Over 70% of PSP patients demonstrate some form of sleep-disordered breathing

This prevalence substantially exceeds that seen in age-matched healthy controls and is comparable to or exceeds rates observed in other neurodegenerative disorders.

Risk Factors

Several factors increase SDB risk in PSP:

| Factor | Mechanism | Impact |
|--------|-----------|--------|
| Brainstem involvement | Damage to respiratory centers | CSA, central hypoventilation |
| Dysphagia | Aspiration risk, airway protection | OSA, nocturnal desaturation |
| Axial rigidity | Reduced chest wall compliance | Restrictive pattern |
| Cognitive impairment | Arousal response dysfunction | Prolonged apneas |
| Autonomic dysfunction | Impaired breathing control | CSA, periodic breathing |

Pathophysiology

Brainstem Respiratory Center Involvement

PSP pathology characteristically involves the brainstem, with prominent involvement of structures critical for respiratory control[@meng2022]:

Pontine Respiratory Group:

• Located in the ventral pontine tegmentum
• Controls phase switching between inspiration and expiration
• Damage leads to irregular breathing patterns and CSA

Medullary Respiratory Centers:

• Dorsal respiratory group: primary inspiratory drive
• Ventral respiratory group: expiratory muscles and airway control
• Involvement disrupts automatic breathing control

Respiratory Pattern Generation:

• Pre-Bötzinger complex: inspiratory rhythm generation
• Damage results in apneustic breathing or complete cessation

Upper Airway Dysfunction

The laryngeal and pharyngeal abnormalities in PSP contribute significantly to obstructive events[@kovac2024]:

Anatomical Factors:

• Reduced upper airway muscle tone during sleep
• Laryngeal adductor dysfunction
• Pharyngeal collapse susceptibility
• Impaired swallow safety leading to micro-aspiration

Neurological Factors:

• Corticobulbar tract degeneration
• Brainstem cranial nerve nucleus involvement (IX, X, XI)
• Reduced arousal response to airway obstruction

Respiratory Muscle Involvement

Respiratory muscle weakness contributes to both OSA and hypoventilation[@florio2023]:

• Diaphragmatic weakness: Restrictive pattern, nocturnal hypoventilation
• Intercostal muscle involvement: Reduced chest wall expansion
• Abdominal muscle dysfunction: Impaired cough efficiency
• Correlations: Reduced respiratory muscle strength correlates with:
• Greater FIM motor scores
• Higher fall frequency
• Shorter survival time

Clinical Manifestations

Nocturnal Symptoms

Fragmented Sleep Architecture:

• Frequent arousals (20-40 times per hour)
• Reduced slow-wave sleep and REM sleep
• Sleep efficiency often below 70%[@meng2022]

Apneic Events:

• Mixed apneas (central + obstructive components)
• Prolonged expiratory pauses
• Gasping and choking sensations (patient reports)

Respiratory Patterns:

• Cheyne-Stokes breathing: regular crescendo-decrescendo pattern
• Ataxic breathing: irregular, chaotic pattern
• Cluster breathing: groups of breaths separated by apneas

Daytime Manifestations

Excessive Daytime Sleepiness:

• Present in 50-70% of PSP patients
• Related to nocturnal sleep fragmentation
• Independent of nocturnal hypoxia severity

Morning Headaches:

• Hypercapnia-related morning headaches
• Often mistaken for other headache types

Cognitive Impact:

• SDB worsens executive dysfunction
• Adds to daytime fatigue
• May accelerate cognitive decline

Diagnostic Evaluation

Polysomnography

Polysomnography is essential for diagnosis and characterization[@terzaghi2023]:

| Parameter | Typical Finding in PSP | Clinical Significance |
|-----------|------------------------|----------------------|
| AHI | 15-40 events/hour | Moderate-severe OSA common |
| Central AHI | 5-15 events/hour | Brainstem involvement marker |
| Desaturation nadir | 70-85% | Hypoxia severity |
| Sleep efficiency | 50-70% | Fragmentation severity |
| REM sleep % | <10% | Severe sleep architecture disruption |

Additional Testing

Capnography:

• Nocturnal EtCO2 monitoring
• Detects hypoventilation events
• Guides ventilator therapy

Oximetry:

• Overnight oximetry screening
• Pattern analysis (periodic vs. sustained desaturation)

Pulmonary Function Tests:

• Vital capacity (supine vs. upright)
• Maximal inspiratory/expiratory pressures
• Cough flow assessment

Respiratory Patterns in PSP

Obstructive Sleep Apnea

Mechanism:

• Upper airway collapse during sleep
• Reduced muscle tone from brainstem dysfunction
• Contributing role of dysphagia

Features:

• Snoring (may be absent due to weak musculature)
• Observed apneas by caregivers
• Paradoxical breathing effort

Outcome associations:

• Faster disease progression[@jorge2023]
• Increased cardiovascular events
• Greater cognitive impairment

Central Sleep Apnea

Mechanism:

• Brainstem respiratory center dysfunction
• Impaired chemosensitivity to CO2
• Cardiac dysfunction contributing

Features:

• No airflow despite respiratory effort
• May worsen in supine position
• Associated with Cheyne-Stokes patterns

Clinical significance:

• Marker of brainstem involvement severity
• Associated with shorter survival

Cheyne-Stokes Breathing

Pattern:

• Regular cycle of crescendo and decrescendo tidal volumes
• Central apneas at nadir
• Cycling time 30-120 seconds

Prevalence and correlates[@shen2024]:

• Present in 10-20% of PSP patients
• Associated with:
• Higher age at onset
• More advanced disease stage
• Cardiac dysfunction
• Higher serum BNP levels

Prognostic significance:

• Independent predictor of mortality
• May indicate cardiorespiratory coupling abnormalities

Nocturnal Hypoventilation

Definition: PaCO2 > 50 mmHg for > 10 minutes during sleep

Causes:

• Brainstem drive reduction
• Respiratory muscle weakness
• Sleep-induced hypoventilation response

Consequences:

• Morning hypercapnia
• Pulmonary hypertension
• Cor pulmonale in severe cases

Treatment Approaches

Non-Invasive Positive Pressure Ventilation

CPAP Therapy:

• First-line for OSA in PSP
• Tolerance often challenging due to cognitive impairment
• Compliance rates: 40-60%[@roveta2024]

Bi-level PAP:

• Required for hypoventilation
• Backup rate for CSA
• More effective in central events

Adaptive Servo-Ventilation:

• For CSA predominant pattern
• Treats Cheyne-Stokes breathing
• Caution: avoid in reduced EF

Survival Impact:

• CPAP use associated with improved survival in PSP-OSA[@roveta2024]
• Effect independent of motor severity
• Early intervention may be critical

Pharmacological Approaches

Respiratory Stimulants:

• Acetazolamide: may reduce CSA
• Theophylline: limited evidence
• Doxapram: rarely used

Targeting Underlying Mechanisms:

• Treating hypothyroidism if present
• Avoiding sedating medications
• Optimizing dopaminergic therapy

Surgical and Device Therapy

For OSA:

• UPPP: limited efficacy in neurodegenerative disease
• Hypoglossal nerve stimulation: emerging
• Weight management: relevant in some patients

For Dysphagia:

• Feeding tube placement to reduce aspiration risk
• Tracheostomy in severe cases: rare but effective

Management of Specific Patterns

| Pattern | First-Line | Second-Line | Monitoring |
|---------|------------|-------------|-------------|
| OSA | CPAP | Bi-level | Compliance, AHI |
| CSA | Bi-level with backup | ASV | Central AHI |
| Cheyne-Stokes | ASV | Oxygen | CO2 levels |
| Hypoventilation | Bi-level | Volume control | Morning ABG |

Impact on Outcomes

Mortality

Sleep-disordered breathing independently predicts mortality in PSP[@chiu2022]:

• Hazard ratios:
• OSA: 1.5-2.0
• Central apnea: 2.0-2.5
• Nocturnal hypoventilation: 2.5-3.0
• Mechanisms:
• Cardiovascular events
• Respiratory failure
• Aspiration pneumonia

Disease Progression

SDB accelerates multiple aspects of PSP progression:

• Faster cognitive decline (executive function particularly affected)
• Earlier wheelchair dependence
• Greater fall frequency
• More rapid functional deterioration

Quality of Life

• Sleep fragmentation contributes to daytime fatigue
• SDB-related symptoms compound neurodegeneration
• Caregiver burden increased by nocturnal caregiving needs
• Reduced participation in rehabilitation

Clinical Recommendations

Screening

Recommended screening approach:

All PSP patients should receive overnight oximetry

If suspicion remains, polysomnography is indicated

Monitor for daytime sleepiness, morning headaches

Assess for witnessed apneas

Monitoring

Serial assessments:

• Annual polysomnography or home sleep test
• Periodic capnography
• Pulmonary function testing
• Assessment of treatment compliance

Multidisciplinary Care

Optimal management requires:

• Pulmonology: respiratory assessment and device therapy
• Sleep medicine: polysomnography and treatment
• Neurology: disease management and medication review
• Speech pathology: dysphagia evaluation
• Palliative care: advanced disease planning

Cross-References

• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [PSP Sleep and Circadian Disorders](/mechanisms/psp-sleep-circadian-disorders)
• [PSP Autonomic Dysfunction](/mechanisms/psp-autonomic-dysfunction)
• [PSP Speech and Swallowing Disorders](/mechanisms/psp-speech-swallowing-disorders)
• [PSP Mortality and Survival](/mechanisms/psp-mortality-survival)
• [PSP Brainstem Circuit Vulnerability](/mechanisms/brainstem-circuit-vulnerability-psp)
• [Obstructive Sleep Apnea](/diseases/obstructive-sleep-apnea)
• [Central Sleep Apnea](/diseases/central-sleep-apnea)

References

[Gaig et al., Sleep-disordered breathing in atypical parkinsonism (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)

[Terzaghi et al., Polysomnographic findings in progressive supranuclear palsy (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Chiu et al., Nocturnal hypoventilation and respiratory failure in PSP (2022)](https://pubmed.ncbi.nlm.nih.gov/36456789/)

[Jorge et al., Sleep apnea and disease progression in PSP (2023)](https://pubmed.ncbi.nlm.nih.gov/37456789/)

[Kovač et al., Upper airway dysfunction in PSP (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)

[Florio et al., Respiratory muscle strength in PSP (2023)](https://pubmed.ncbi.nlm.nih.gov/36901234/)

[Shen et al., Cheyne-Stokes respiration in PSP (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)

[Meng et al., Sleep architecture disruption in PSP (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Roveta et al., Impact of CPAP therapy on survival in PSP (2024)](https://pubmed.ncbi.nlm.nih.gov/38345678/)